BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$903M |
| 2 |
Apple
AAPL
|
+$854M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$771M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$696M |
| 5 |
Oracle
ORCL
|
+$621M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$1.55B |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$976M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$928M |
| 4 |
AET
Aetna Inc
AET
|
+$832M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.45% |
| 2 | Technology | 14.96% |
| 3 | Healthcare | 12.92% |
| 4 | Industrials | 10.26% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Cytosorbents Corp
CTSO
$23.7M
| $911K | ﹤0.01% |
140,137
+3,320
| +2% | +$21.1K |
|
3827
Vaalco Energy
EGY
$551M
| $905K | ﹤0.01% |
1,298,945
+397
| +0% | +$310 |
|
3828
Elbit Systems
ESLT
$39.8B
| $904K | ﹤0.01% |
+6,784
| New | +$971K |
|
|
PCOM
3829
DELISTED
Points.com Inc. Common Shares
PCOM
| $895K | ﹤0.01% |
86,943
+55,184
| +174% | +$615K |
|
3830
iShares California Muni Bond ETF
CMF
$4.6B
| $893K | ﹤0.01% |
15,090
+4,428
| +42% | +$262K |
|
|
NAVB
3831
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $892K | ﹤0.01% |
124,515
+177
| +0.1% | +$1.5K |
|
3832
Smith Micro Software
SMSI
$15.7M
| $891K | ﹤0.01% |
7,838
+6
| +0.1% | +$487 |
|
|
GNMX
3833
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $890K | ﹤0.01% |
741,716
+3,092
| +0.4% | +$4.22K |
|
3834
Coca-Cola Femsa
KOF
$22.8B
| $882K | ﹤0.01% |
12,659
+1,354
| +12% | +$94.6K |
|
3835
Rocket Pharmaceuticals
RCKT
$376M
| $881K | ﹤0.01% |
84,441
+830
| +1% | +$8.23K |
|
|
GARS
3836
DELISTED
Garrison Capital Inc.
GARS
| $879K | ﹤0.01% |
108,414
+11,119
| +11% | +$92.7K |
|
3837
Innodata
INOD
$2.29B
| $872K | ﹤0.01% |
641,223
+3,452
| +0.5% | +$4.14K |
|
3838
AmeriServ Financial
ASRV
$74.6M
| $869K | ﹤0.01% |
209,394
+2,824
| +1% | +$11.6K |
|
|
TSG
3839
DELISTED
The Stars Group Inc.
TSG
| $862K | ﹤0.01% |
+37,000
| New | +$806K |
|
|
QADB
3840
DELISTED
QAD Inc. Class B
QADB
| $854K | ﹤0.01% |
29,459
| – | – |
|
|
RGLS
3841
DELISTED
Regulus Therapeutics
RGLS
| $852K | ﹤0.01% |
6,817
+73
| +1% | +$9.24K |
|
3842
Vanguard Morningstar Growth ETF
VUG
$230B
| $850K | ﹤0.01% |
36,288
+4,620
| +15% | +$106K |
|
3843
Restaurant Brands International
QSR
$25.6B
| $841K | ﹤0.01% |
13,686
+12,807
| +1,457% | +$821K |
|
3844
Inuvo
INUV
$18M
| $838K | ﹤0.01% |
103,475
+307
| +0.3% | +$2.64K |
|
|
MATR
3845
DELISTED
Mattersight Corp.
MATR
| $837K | ﹤0.01% |
328,177
+2,776
| +0.9% | +$7.37K |
|
|
RDS.B
3846
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $835K | ﹤0.01% |
12,230
+3,992
| +48% | +$259K |
|
|
DEST
3847
DELISTED
Destination Maternity Corporation
DEST
| $822K | ﹤0.01% |
277,230
+1,608
| +0.6% | +$4.05K |
|
|
AMCA
3848
DELISTED
iShares Russell 1000 Pure U.S. Revenue ETF
AMCA
| $821K | ﹤0.01% |
30,000
-20,000
| -40% | -$525K |
|
3849
Odyssey Marine Exploration
OMEX
$43.2M
| $816K | ﹤0.01% |
216,802
+996
| +0.5% | +$3.92K |
|
|
MARK
3850
DELISTED
Remark Holdings, Inc.
MARK
| $804K | ﹤0.01% |
8,265
+2,529
| +44% | +$149K |
|
Similar funds
BlackRock's Q4 2017 Portfolio in Review
As of Q4 2017, BlackRock held 5,151 positions worth $2.1T, up 6.1% from $1.98T the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BlackRock's Q4 2017 filing shows 147 new, 3,054 increased, 1,214 reduced and 177 closed positions. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M. The largest sale was CR Bard Inc., an estimated $1.55B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- BlackRock's largest Q4 2017 buy was iShares Core MSCI International Developed Markets ETF: 13,434,810 shares worth $786M.
- BlackRock added most to Meta Platforms (Facebook) in Q4 2017, an estimated $903M increase.
- BlackRock's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $928M.
- BlackRock fully exited CR Bard Inc. in Q4 2017, selling an estimated $1.55B.
- BlackRock's ten largest holdings make up 13% of its $2.1T portfolio in Q4 2017.
- BlackRock opened 147 new positions and closed 177 in Q4 2017.
- BlackRock's portfolio value rose 6.1% quarter-over-quarter to $2.1T.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.